CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 76 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2020. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,662,852 | -33.6% | 46,216 | -17.8% | 0.33% | -37.0% |
| Q4 2022 | $2,505,369 | -46.3% | 56,212 | -34.9% | 0.52% | -34.1% |
| Q3 2021 | $4,665,000 | +176.0% | 86,399 | +71.0% | 0.79% | +201.5% |
| Q2 2021 | $1,690,000 | -3.8% | 50,533 | -49.6% | 0.26% | -9.4% |
| Q4 2020 | $1,757,000 | -16.1% | 100,259 | -29.0% | 0.29% | -41.9% |
| Q3 2020 | $2,093,000 | +132.8% | 141,129 | +104.2% | 0.50% | +149.2% |
| Q2 2020 | $899,000 | – | 69,126 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |